Diversey Holdings, Ltd.

NasdaqGS:DSEY Stock Report

Market Cap: US$2.7b

Diversey Holdings Valuation

Is DSEY undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of DSEY when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: DSEY ($8.39) is trading below our estimate of fair value ($10.19)

Significantly Below Fair Value: DSEY is trading below fair value, but not by a significant amount.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for DSEY?

Key metric: As DSEY is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for DSEY. This is calculated by dividing DSEY's market cap by their current revenue.
What is DSEY's PS Ratio?
PS Ratio1x
SalesUS$2.80b
Market CapUS$2.72b

Price to Sales Ratio vs Peers

How does DSEY's PS Ratio compare to its peers?

The above table shows the PS ratio for DSEY vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average1.6x
MTX Minerals Technologies
1.2x4.8%US$2.5b
KWR Quaker Chemical
1.6x3.0%US$2.9b
IOSP Innospec
1.6x3.3%US$2.9b
SXT Sensient Technologies
2.1x4.9%US$3.2b
DSEY Diversey Holdings
1x4.5%US$2.7b

Price-To-Sales vs Peers: DSEY is good value based on its Price-To-Sales Ratio (1x) compared to the peer average (1.5x).


Price to Sales Ratio vs Industry

How does DSEY's PS Ratio compare vs other companies in the US Chemicals Industry?

10 CompaniesPrice / SalesEstimated GrowthMarket Cap
TSE Trinseo
0.03x5.0%US$115.06m
ALTO Alto Ingredients
0.1x3.1%US$106.54m
BON Bon Natural Life
0.2xn/aUS$5.84m
ABLT American Biltrite
0.02xn/aUS$2.91m
DSEY 1.0xIndustry Avg. 1.4xNo. of Companies17PS01.22.43.64.86+
10 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: DSEY is good value based on its Price-To-Sales Ratio (1x) compared to the US Chemicals industry average (1.3x).


Price to Sales Ratio vs Fair Ratio

What is DSEY's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

DSEY PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio1x
Fair PS Ratio1.3x

Price-To-Sales vs Fair Ratio: DSEY is good value based on its Price-To-Sales Ratio (1x) compared to the estimated Fair Price-To-Sales Ratio (1.3x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst DSEY forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Currentn/a
US$8.41
0%
0.4%US$8.50US$8.40n/a9
Nov ’25n/a
US$8.41
0%
0.4%US$8.50US$8.40n/a9
Oct ’25n/a
US$8.41
0%
0.4%US$8.50US$8.40n/a9
Sep ’25n/a
US$8.41
0%
0.4%US$8.50US$8.40n/a9
Aug ’25n/a
US$8.41
0%
0.4%US$8.50US$8.40n/a9
Jul ’25n/a
US$8.41
0%
0.4%US$8.50US$8.40n/a9
Jun ’25n/a
US$8.41
0%
0.4%US$8.50US$8.40n/a9
May ’25n/a
US$8.41
0%
0.4%US$8.50US$8.40n/a9
Apr ’25n/a
US$8.41
0%
0.4%US$8.50US$8.40n/a9
Mar ’25n/a
US$8.41
0%
0.4%US$8.50US$8.40n/a9
Feb ’25n/a
US$8.41
0%
0.4%US$8.50US$8.40n/a9
Jan ’25n/a
US$8.41
0%
0.4%US$8.50US$8.40n/a9
Dec ’24n/a
US$8.41
0%
0.4%US$8.50US$8.40n/a9
Nov ’24n/a
US$8.41
0%
0.4%US$8.50US$8.40n/a9
Oct ’24n/a
US$8.41
0%
0.4%US$8.50US$8.40n/a9
Sep ’24n/a
US$8.41
0%
0.4%US$8.50US$8.40n/a9
Aug ’24n/a
US$8.41
0%
0.4%US$8.50US$8.40n/a9
Jul ’24US$8.39
US$8.41
+0.3%
0.4%US$8.50US$8.40n/a9
Jun ’24US$8.33
US$8.41
+1.0%
0.4%US$8.50US$8.40n/a9
May ’24US$8.14
US$8.41
+3.3%
0.4%US$8.50US$8.40n/a9
Apr ’24US$8.09
US$8.42
+4.1%
0.5%US$8.50US$8.40n/a9
Mar ’24US$5.96
US$6.90
+15.7%
20.2%US$9.00US$5.00n/a13
Feb ’24US$6.25
US$6.97
+11.5%
20.5%US$9.00US$5.00n/a12
Jan ’24US$4.26
US$7.05
+65.6%
20.4%US$9.00US$5.00n/a12
Dec ’23US$5.17
US$7.17
+38.6%
20.2%US$9.00US$5.00n/a11
Nov ’23US$5.16
US$8.55
+65.6%
30.6%US$15.00US$5.50n/a11

Analyst Forecast: Target price is less than 20% higher than the current share price.


Discover undervalued companies